Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

QUOTED. 12 February 2020. Tomer Lark.

Executive Summary

Israel start-up Serenno Medical is planning a US launch for the Sentinel continuous urine output monitor for automatic monitoring and detection of acute kidney injury in patients treated in an intensive care unit. See what Serenno's CEO, Tomer Lark, said about it here.

“There is a clear unmet medical need for the automated monitoring of urine output for ICU patients. Repeated attempts at creating a device that delivers quality data from urine output and can alert physicians to possible kidney damage have, so far, not met with commercial success." – Tomer Lark, CEO, Serenno Medical

Click here for a free trial of Medtech Insight

Related Content

Topics

UsernamePublicRestriction

Register

MT126235

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel